[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global eterinary Vaccines Sales Market Report Forecast 2017-2021

March 2017 | 108 pages | ID: GA57D88A44BEN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
The study is a source of reliable data on:
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
  • United States
  • China
  • Europe
  • Japan
The Major players reported in the market include:
GE Healthcare
Bayer Healthcare
Boehringer Ingelheim
Ceva Animal Health
Elanco Animal Health (Eli Lilly)
Heska Corporation
Merck Animal Healthcare
Merial Inc. (SANOFI)
Virbac
Product Segment Analysis:
Live Vaccine
DNA Vaccine
Inactivated Vaccines
Application Segment Analysis:
Livestock
Poultry
Application 3

REASONS FOR BUYING THIS REPORT
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified analysis of major market segments
Global eterinary Vaccines Sales Market Report Forecast 2017-2021

1 ETERINARY VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of eterinary Vaccines
1.2 Classification of eterinary Vaccines
  1.2.1 Live Vaccine
  1.2.2 DNA Vaccine
  1.2.3 Inactivated Vaccines
1.3 Application of eterinary Vaccines
  1.3.2 Livestock
  1.3.3 Poultry
  1.3.4 Application
1.4 eterinary Vaccines Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of eterinary Vaccines (2012-2021)
  1.5.1 Global eterinary Vaccines Sales and Growth Rate (2012-2021)
  1.5.2 Global eterinary Vaccines Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON ETERINARY VACCINES INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 ETERINARY VACCINES MANUFACTURING COST ANALYSIS

3.1 eterinary Vaccines Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of eterinary Vaccines

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 eterinary Vaccines Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of eterinary Vaccines Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL ETERINARY VACCINES COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global eterinary Vaccines Market Competition by Manufacturers
  5.1.1 Global eterinary Vaccines Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global eterinary Vaccines Revenue and Share by Manufacturers (2012-2017)
5.2 Global eterinary Vaccines (Volume and Value) by Type
  5.5.1 Global eterinary Vaccines Sales and Market Share by Type (2012-2017)
  5.5.2 Global eterinary Vaccines Revenue and Market Share by Type (2012-2017)
5.3 Global eterinary Vaccines (Volume and Value) by Regions
  5.3.1 Global eterinary Vaccines Sales and Market Share by Regions (2012-2017)
  5.3.2 Global eterinary Vaccines Revenue and Market Share by Regions (2012-2017)
5.4 Global eterinary Vaccines (Volume) by Application

6 UNITED STATES ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 United States eterinary Vaccines Sales and Value (2012-2017)
  6.1.1 United States eterinary Vaccines Sales and Growth Rate (2012-2017)
  6.1.2 United States eterinary Vaccines Revenue and Growth Rate (2012-2017)
  6.1.3 United States eterinary Vaccines Sales Price Trend (2012-2017)
6.2 United States eterinary Vaccines Sales and Market Share by Manufacturers
6.3 United States eterinary Vaccines Sales and Market Share by Type
6.4 United States eterinary Vaccines Sales and Market Share by Application

7 CHINA ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 China eterinary Vaccines Sales and Value (2012-2017)
  7.1.1 China eterinary Vaccines Sales and Growth Rate (2012-2017)
  7.1.2 China eterinary Vaccines Revenue and Growth Rate (2012-2017)
  7.1.3 China eterinary Vaccines Sales Price Trend (2012-2017)
7.2 China eterinary Vaccines Sales and Market Share by Manufacturers
7.3 China eterinary Vaccines Sales and Market Share by Type
7.4 China eterinary Vaccines Sales and Market Share by Application

8 EUROPE ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Europe eterinary Vaccines Sales and Value (2012-2017)
  8.1.1 Europe eterinary Vaccines Sales and Growth Rate (2012-2017)
  8.1.2 Europe eterinary Vaccines Revenue and Growth Rate (2012-2017)
  8.1.3 Europe eterinary Vaccines Sales Price Trend (2012-2017)
8.2 Europe eterinary Vaccines Sales and Market Share by Manufacturers
8.3 Europe eterinary Vaccines Sales and Market Share by Type
8.4 Europe eterinary Vaccines Sales and Market Share by Application

9 JAPAN ETERINARY VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Japan eterinary Vaccines Sales and Value (2012-2017)
  9.1.1 Japan eterinary Vaccines Sales and Growth Rate (2012-2017)
  9.1.2 Japan eterinary Vaccines Revenue and Growth Rate (2012-2017)
  9.1.3 Japan eterinary Vaccines Sales Price Trend (2012-2017)
9.2 Japan eterinary Vaccines Sales and Market Share by Manufacturers
9.3 Japan eterinary Vaccines Sales and Market Share by Type
9.4 Japan eterinary Vaccines Sales and Market Share by Application

10 GLOBAL ETERINARY VACCINES MANUFACTURERS ANALYSIS

10.1 GE Healthcare
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Bayer Healthcare
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Boehringer Ingelheim
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Ceva Animal Health
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Elanco Animal Health (Eli Lilly)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Heska Corporation
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Merck Animal Healthcare
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Merial Inc. (SANOFI)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Virbac
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL ETERINARY VACCINES MARKET FORECAST (2017-2021)

13.1 Global eterinary Vaccines Sales, Revenue Forecast (2017-2021)
13.2 Global eterinary Vaccines Sales Forecast by Regions (2017-2021)
13.3 Global eterinary Vaccines Sales Forecast by Type (2017-2021)
13.4 Global eterinary Vaccines Sales Forecast by Application (2017-2021)

14 APPENDIX
LIST OF TABLES AND FIGURES

Figure Picture of eterinary Vaccines
Table Classification of eterinary Vaccines
Figure Global Sales Market Share of eterinary Vaccines by Type in 2015
Table Applications of eterinary Vaccines
Figure Global Sales Market Share of eterinary Vaccines by Application in 2015
Figure United States eterinary Vaccines Revenue and Growth Rate (2012-2021)
Figure China eterinary Vaccines Revenue and Growth Rate (2012-2021)
Figure Europe eterinary Vaccines Revenue and Growth Rate (2012-2021)
Figure Japan eterinary Vaccines Revenue and Growth Rate (2012-2021)
Figure Global eterinary Vaccines Sales and Growth Rate (2012-2021)
Figure Global eterinary Vaccines Revenue and Growth Rate (2012-2021)
Table Global eterinary Vaccines Sales of Key Manufacturers (2012-2017)
Table Global eterinary Vaccines Sales Share by Manufacturers (2012-2017)
Figure 2015 eterinary Vaccines Sales Share by Manufacturers
Figure 2016 eterinary Vaccines Sales Share by Manufacturers
Table Global eterinary Vaccines Revenue by Manufacturers (2012-2017)
Table Global eterinary Vaccines Revenue Share by Manufacturers (2012-2017)
Table 2015 Global eterinary Vaccines Revenue Share by Manufacturers
Table 2016 Global eterinary Vaccines Revenue Share by Manufacturers
Table Global eterinary Vaccines Sales and Market Share by Type (2012-2017)
Table Global eterinary Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of eterinary Vaccines by Type (2012-2017)
Figure Global eterinary Vaccines Sales Growth Rate by Type (2012-2017)
Table Global eterinary Vaccines Revenue and Market Share by Type (2012-2017)
Table Global eterinary Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of eterinary Vaccines by Type (2012-2017)
Figure Global eterinary Vaccines Revenue Growth Rate by Type (2012-2017)
Table Global eterinary Vaccines Sales and Market Share by Regions (2012-2017)
Table Global eterinary Vaccines Sales Share by Regions (2012-2017)
Figure Sales Market Share of eterinary Vaccines by Regions (2012-2017)
Figure Global eterinary Vaccines Sales Growth Rate by Regions (2012-2017)
Table Global eterinary Vaccines Revenue and Market Share by Regions (2012-2017)
Table Global eterinary Vaccines Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of eterinary Vaccines by Regions (2012-2017)
Figure Global eterinary Vaccines Revenue Growth Rate by Regions (2012-2017)
Table Global eterinary Vaccines Sales and Market Share by Application (2012-2017)
Table Global eterinary Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of eterinary Vaccines by Application (2012-2017)
Figure Global eterinary Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States eterinary Vaccines Sales and Growth Rate (2012-2017)
Figure United States eterinary Vaccines Revenue and Growth Rate (2012-2017)
Figure United States eterinary Vaccines Sales Price Trend (2012-2017)
Table United States eterinary Vaccines Sales by Manufacturers (2012-2017)
Table United States eterinary Vaccines Market Share by Manufacturers (2012-2017)
Table United States eterinary Vaccines Sales by Type (2012-2017)
Table United States eterinary Vaccines Market Share by Type (2012-2017)
Table United States eterinary Vaccines Sales by Application (2012-2017)
Table United States eterinary Vaccines Market Share by Application (2012-2017)
Figure China eterinary Vaccines Sales and Growth Rate (2012-2017)
Figure China eterinary Vaccines Revenue and Growth Rate (2012-2017)
Figure China eterinary Vaccines Sales Price Trend (2012-2017)
Table China eterinary Vaccines Sales by Manufacturers (2012-2017)
Table China eterinary Vaccines Market Share by Manufacturers (2012-2017)
Table China eterinary Vaccines Sales by Type (2012-2017)
Table China eterinary Vaccines Market Share by Type (2012-2017)
Table China eterinary Vaccines Sales by Application (2012-2017)
Table China eterinary Vaccines Market Share by Application (2012-2017)
Figure Europe eterinary Vaccines Sales and Growth Rate (2012-2017)
Figure Europe eterinary Vaccines Revenue and Growth Rate (2012-2017)
Figure Europe eterinary Vaccines Sales Price Trend (2012-2017)
Table Europe eterinary Vaccines Sales by Manufacturers (2012-2017)
Table Europe eterinary Vaccines Market Share by Manufacturers (2012-2017)
Table Europe eterinary Vaccines Sales by Type (2012-2017)
Table Europe eterinary Vaccines Market Share by Type (2012-2017)
Table Europe eterinary Vaccines Sales by Application (2012-2017)
Table Europe eterinary Vaccines Market Share by Application (2012-2017)
Figure Japan eterinary Vaccines Sales and Growth Rate (2012-2017)
Figure Japan eterinary Vaccines Revenue and Growth Rate (2012-2017)
Figure Japan eterinary Vaccines Sales Price Trend (2012-2017)
Table Japan eterinary Vaccines Sales by Manufacturers (2012-2017)
Table Japan eterinary Vaccines Market Share by Manufacturers (2012-2017)
Table Japan eterinary Vaccines Sales by Type (2012-2017)
Table Japan eterinary Vaccines Market Share by Type (2012-2017)
Table Japan eterinary Vaccines Sales by Application (2012-2017)
Table Japan eterinary Vaccines Market Share by Application (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GE Healthcare eterinary Vaccines Global Market Share (2012-2017)
Table Bayer Healthcare Basic Information List
Table Bayer Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Healthcare eterinary Vaccines Global Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim eterinary Vaccines Global Market Share (2012-2017)
Table Ceva Animal Health Basic Information List
Table Ceva Animal Health eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ceva Animal Health eterinary Vaccines Global Market Share (2012-2017)
Table Elanco Animal Health (Eli Lilly) Basic Information List
Table Elanco Animal Health (Eli Lilly) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Elanco Animal Health (Eli Lilly) eterinary Vaccines Global Market Share (2012-2017)
Table Heska Corporation Basic Information List
Table Heska Corporation eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Heska Corporation eterinary Vaccines Global Market Share (2012-2017)
Table Merck Animal Healthcare Basic Information List
Table Merck Animal Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Animal Healthcare eterinary Vaccines Global Market Share (2012-2017)
Table Merial Inc. (SANOFI) Basic Information List
Table Merial Inc. (SANOFI) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merial Inc. (SANOFI) eterinary Vaccines Global Market Share (2012-2017)
Table Virbac Basic Information List
Table Virbac eterinary Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Virbac eterinary Vaccines Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of eterinary Vaccines
Figure Manufacturing Process Analysis of eterinary Vaccines
Figure eterinary Vaccines Industrial Chain Analysis
Table Raw Materials Sources of eterinary Vaccines Major Manufacturers in 2015
Table Major Buyers of eterinary Vaccines
Table Distributors/Traders List
Figure Global eterinary Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Global eterinary Vaccines Revenue and Growth Rate Forecast (2017-2021)
Table Global eterinary Vaccines Sales Forecast by Regions (2017-2021)
Table Global eterinary Vaccines Sales Forecast by Type (2017-2021)
Table Global eterinary Vaccines Sales Forecast by Application (2017-2021)


More Publications